{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:03:55Z","timestamp":1791497035190,"version":"4.3.4"},"reference-count":25,"publisher":"Scientific Scholar","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,1]]},"abstract":"\n Background & objectives:<\/jats:title>\n Celiac disease (CD) can exist in various forms in type 1 diabetes (T1D) patients and can remain undetected, leading to severe complications. This study was aimed to evaluate five commercially available anti-tissue transglutaminase (tTG) ELISA kits with distinct formats for the detection of CD and potential CD in T1D patients. Clinical and demographic profiles of the patients with different disease subsets were also studied.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Fifty T1D patients with classical and non-classical symptoms of CD and 100 T1D patients without any symptoms of CD were included in this study. Anti-tTG autoantibody levels were estimated by five ELISA kits followed by histological examination of duodenal biopsy. HLA DQ2-DQ8 and DRB1-DQB1 typing was done, and serum levels for transforming growth factor (TGF)-\u03b21 were also estimated.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n Assay format detecting anti-tTG IgA antibodies against recombinant antigens along with neopeptides of gliadin was most efficient in the detection of CD in symptomatic patients, and assay format detecting IgA+IgG helped in the detection of potential CD in asymptomatic T1D patients. These findings were supported by histological examination and human leucocyte antigen analysis. Patients with potential CD were found to have markedly deranged glycaemic control parameters and also had significantly raised serum levels of TGF-\u03b21, (P<\/jats:italic><0.05) compared to T1D patients.<\/jats:p>\n <\/jats:sec>\n \n Interpretation & conclusions:<\/jats:title>\n Potential CD can be frequently seen in T1D patients. This can be attributed to the dietary patterns prevalent in the subcontinent and the genetic basis of the disease. Anti-tTG IgA+IgG antibodies can be useful in the detection of these potential CD cases in T1D patients. Early intervention with gluten-free diet can be considered in these patients for better disease management.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1136_16","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T05:51:35Z","timestamp":1555912295000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Role of anti-tissue transglutaminase IgA+IgG antibodies in detection of potential celiac disease in patients with type 1 diabetes"],"prefix":"10.25259","volume":"149","author":[{"given":"Navchetan","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjana W.","family":"Minz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay K.","family":"Bhadada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biman","family":"Saikia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devi","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashi","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagdeep","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babu R.","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh K.","family":"Kochhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Vaiphei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","reference":[{"key":"R1-4-20241212","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.yapd.2008.07.001","article-title":"Celiac disease: Pathophysiology, clinical manifestations, and associated autoimmune conditions","volume":"55","author":"Barker","year":"2008","journal-title":"Adv Pediatr"},{"key":"R2-4-20241212","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.autrev.2008.05.006","article-title":"Celiac disease: From gluten to autoimmunity","volume":"7","author":"Briani","year":"2008","journal-title":"Autoimmun Rev"},{"key":"R3-4-20241212","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1053\/gast.2000.8521","article-title":"Current concepts of celiac disease pathogenesis","volume":"119","author":"Schuppan","year":"2000","journal-title":"Gastroenterology"},{"key":"R4-4-20241212","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0698-713","article-title":"Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease","volume":"4","author":"Molberg","year":"1998","journal-title":"Nat Med"},{"key":"R5-4-20241212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1146\/annurev.immunol.18.1.53","article-title":"Molecular basis of celiac disease","volume":"18","author":"Sollid","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"R6-4-20241212","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1210\/er.2001-0035","article-title":"Endocrinological disorders and celiac disease","volume":"23","author":"Collin","year":"2002","journal-title":"Endocr Rev"},{"key":"R7-4-20241212","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1053\/gast.2001.22123","article-title":"Current approaches to diagnosis and treatment of celiac disease: An evolving spectrum","volume":"120","author":"Fasano","year":"2001","journal-title":"Gastroenterology"},{"key":"R8-4-20241212","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nrgastro.2010.23","article-title":"The spectrum of celiac disease: Epidemiology, clinical aspects and treatment","volume":"7","author":"Tack","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R9-4-20241212","first-page":"5","article-title":"Celiac disease: Can we avert the impending epidemic in India?","volume":"133","author":"Ramakrishna","year":"2011","journal-title":"Indian J Med Res"},{"key":"R11-4-20241212","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European society for pediatric gastroenterology, hepatology, and nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"R12-4-20241212","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1111\/j.1440-1746.2006.04560.x","article-title":"Celiac disease: India on the global map","volume":"21","author":"Yachha","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R13-4-20241212","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1440-1746.2010.06606.x","article-title":"Prevalence of celiac disease in the northern part of India: A community based study","volume":"26","author":"Makharia","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R14-4-20241212","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1440-1746.2010.06508.x","article-title":"Prevalence and clinical profile of celiac disease in type 1 diabetes mellitus in North India","volume":"26","author":"Bhadada","year":"2011","journal-title":"J Gastroenterol Hepatol"},{"key":"R15-4-20241212","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2337\/dc11-2171","article-title":"IgA anti-transglutaminase autoantibodies at type 1 diabetes onset are less frequent in adult patients and are associated with a general celiac-specific lower immune response in comparison with nondiabetic celiac patients at diagnosis","volume":"35","author":"Tiberti","year":"2012","journal-title":"Diabetes Care"},{"key":"R16-4-20241212","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.3748\/wjg.v11.i24.3762","article-title":"Comparison of six human anti-transglutaminase ELISA-tests in the diagnosis of celiac disease in the Saharawi population","volume":"11","author":"Fern\u00e1ndez","year":"2005","journal-title":"World J Gastroenterol"},{"key":"R17-4-20241212","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1471-230X-13-19","article-title":"Intestinal biopsy is not always required to diagnose celiac disease: A retrospective analysis of combined antibody tests","volume":"13","author":"B\u00fcrgin-Wolff","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"R18-4-20241212","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/gut.47.3.366","article-title":"IgG(1) antiendomysium and IgG antitissue transglutaminase (anti-tTG) antibodies in coeliac patients with selective IgA deficiency. Working Groups on Celiac Disease of SIGEP and Club Del Tenue","volume":"47","author":"Cataldo","year":"2000","journal-title":"Gut"},{"key":"R19-4-20241212","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1203\/00006450-200011000-00006","article-title":"Celiac disease diagnosis in misdiagnosed children","volume":"48","author":"Picarelli","year":"2000","journal-title":"Pediatr Res"},{"key":"R20-4-20241212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/j.1365-2249.2005.02866.x","article-title":"Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus","volume":"142","author":"Picarelli","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"R21-4-20241212","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1097\/00042737-199910000-00019","article-title":"The histopathology of coeliac disease: Time for a standardized report scheme for pathologists","volume":"11","author":"Oberhuber","year":"1999","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"R22-4-20241212","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1136\/pmj.76.898.466","article-title":"Endomysial antibody in the diagnosis and management of coeliac disease","volume":"76","author":"James","year":"2000","journal-title":"Postgrad Med J"},{"key":"R23-4-20241212","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.molimm.2015.06.026","article-title":"IgG anti-tTG responses in different autoimmune conditions differ in their epitope targets and subclass usage","volume":"67","author":"Comerford","year":"2015","journal-title":"Mol Immunol"},{"key":"R24-4-20241212","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.2337\/diacare.26.6.1932","article-title":"Screening for celiac disease in children with type 1 diabetes: Two views of the controversy","volume":"26","author":"Freemark","year":"2003","journal-title":"Diabetes Care"},{"key":"R25-4-20241212","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/jaut.1999.0303","article-title":"One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease-associated transglutaminase autoantibodies","volume":"13","author":"Bao","year":"1999","journal-title":"J Autoimmun"},{"key":"R26-4-20241212","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/mi.2014.102","article-title":"Lessons from rodent models in celiac disease","volume":"8","author":"Korneychuk","year":"2015","journal-title":"Mucosal Immunol"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201949010-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T23:01:03Z","timestamp":1751497263000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/role-of-anti-tissue-transglutaminase-igaigg-antibodies-in-detection-of-potential-celiac-disease-in-patients-with-type-1-diabetes\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1136_16","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2019,1]]}}}